The importance of gestational sac size of ectopic pregnancy in response to single-dose methotrexate.

ISRN obstetrics and gynecology Pub Date : 2013-05-14 Print Date: 2013-01-01 DOI:10.1155/2013/269425
Parichehr Kimiaei, Zahra Khani, Azadeh Marefian, Maryam Gholampour Ghavamabadi, Maryam Salimnejad
{"title":"The importance of gestational sac size of ectopic pregnancy in response to single-dose methotrexate.","authors":"Parichehr Kimiaei,&nbsp;Zahra Khani,&nbsp;Azadeh Marefian,&nbsp;Maryam Gholampour Ghavamabadi,&nbsp;Maryam Salimnejad","doi":"10.1155/2013/269425","DOIUrl":null,"url":null,"abstract":"<p><p>This retrospective cohort study was designed in a selective group of 185 patients diagnosed with and treated for ectopic pregnancy. Intramuscular administration of a single dose of methotrexate (50 mg/m(2)) was performed to measure predictors of failure or resistance to treatment necessitating surgical intervention. During the time of treatment with a single dose of MTX, 20 patients (10.8%) failed to response, in which 6 of 20 (30%) indicated side effects to MTX and rupture of the ectopic pregnancy. Remaining cases (n = 14) showed resistance to the drug; the level of β -hCG did not fall at least 15% during 7 days after treatment and necessitated laparotomy. In backward-step analysis by multiple logistic regressions of various types of predictor factors, size of gestational sac (coefficient = 1.91, OR = 6.78, 95% confidence interval = 3.18-8.22) and baseline level β -hCG (coefficient = 1.60, OR = 5.0, 95% confidence interval = 4.26-6.72) had significant correlation with leading EP patients failing to response to MTX. This study suggests that further investigation for finding relative contraindications of MTX treatment in EP women should be considered on the gestational sac size because other variables are in the causal pathway of this variable.</p>","PeriodicalId":73520,"journal":{"name":"ISRN obstetrics and gynecology","volume":"2013 ","pages":"269425"},"PeriodicalIF":0.0000,"publicationDate":"2013-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/269425","citationCount":"13","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN obstetrics and gynecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2013/269425","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2013/1/1 0:00:00","PubModel":"Print","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 13

Abstract

This retrospective cohort study was designed in a selective group of 185 patients diagnosed with and treated for ectopic pregnancy. Intramuscular administration of a single dose of methotrexate (50 mg/m(2)) was performed to measure predictors of failure or resistance to treatment necessitating surgical intervention. During the time of treatment with a single dose of MTX, 20 patients (10.8%) failed to response, in which 6 of 20 (30%) indicated side effects to MTX and rupture of the ectopic pregnancy. Remaining cases (n = 14) showed resistance to the drug; the level of β -hCG did not fall at least 15% during 7 days after treatment and necessitated laparotomy. In backward-step analysis by multiple logistic regressions of various types of predictor factors, size of gestational sac (coefficient = 1.91, OR = 6.78, 95% confidence interval = 3.18-8.22) and baseline level β -hCG (coefficient = 1.60, OR = 5.0, 95% confidence interval = 4.26-6.72) had significant correlation with leading EP patients failing to response to MTX. This study suggests that further investigation for finding relative contraindications of MTX treatment in EP women should be considered on the gestational sac size because other variables are in the causal pathway of this variable.

异位妊娠囊大小对单剂量甲氨蝶呤反应的重要性。
本回顾性队列研究选择了185例诊断为异位妊娠并接受治疗的患者。肌内注射单剂量甲氨蝶呤(50 mg/m(2)),以测量治疗失败或抵抗治疗需要手术干预的预测因素。在单剂量MTX治疗期间,20例(10.8%)患者无效,其中6例(30%)出现MTX副作用和异位妊娠破裂。其余病例(n = 14)显示耐药;β -hCG水平在治疗后7天内没有下降至少15%,需要开腹手术。多种预测因素的多元logistic回归分析显示,妊娠囊大小(系数= 1.91,OR = 6.78, 95%可信区间= 3.18 ~ 8.22)和基线水平β -hCG(系数= 1.60,OR = 5.0, 95%可信区间= 4.26 ~ 6.72)与EP患者MTX治疗无效有显著相关性。本研究提示,妊娠期妊娠妇女MTX治疗的相对禁忌症应考虑进一步的调查,因为其他变量在该变量的因果途径中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信